ChemDiv and Abbott expand collaboration to develop branded generic pharmaceuticals for high growth emerging markets

ChemDiv today announced the continued expansion of its Modeling & Simulation Services platform, highlighted by the signing of its tenth collaborator in 2026, Mondego Bio (Coimbra, Portugal), f...

ChemDiv, Inc. Highlights Successful Deployment of Proprietary CNS Drug Discovery Platform, Advancing Neurodegenerative Programs for Polku Therapeutics and Brenig Therapeutics

Happy Holidays from ChemDiv,Inc

ChemDiv Extends CMC Services Collaboration for Ratutrelvir, a Potential Best-in-Class COVID-19 Therapeutic Advancing in Phase 2 Clinical Trials